Potential Side Effects: Nausea, diarrhea, constipation, vomiting, and decreased appetite Dysesthesia (abnormal sense of touch) reported in some cases Retatrutide is not yet FDA-approved and is only available in clinical trials
In rodent models, the majority of POMC/CART neurons have GLP-1 receptors, predominantly in the arcuate nucleus of the hypothalamus [118]
Animal study safety signals Animal studies provide longer-term data, though with obvious limitations in translating to humans
This combination often leads to lower calorie intake and gradual, sustainable weight loss when used consistently
10.1016/s0140-6736(21)00213-0 16
At the same time, GHRP-2 is believed to possibly inhibit the secretion of the appetite-reducing hormone, melanocyte-stimulating hormone (-MSH), thus shifting the equilibrium towards increased hunger and encouraging dietary intake